Electromed (ELMD) Net Cash Flow (QoQ) (2010 - 2026)
Electromed (ELMD) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Electromed | 313.26 Mn | 296.27 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,091.93% |
| Dec 31, 2025 | 72.57% |
| Sep 30, 2025 | -2,448.00% |
| Jun 30, 2025 | 105.01% |
| Mar 31, 2025 | -142.09% |
| Dec 31, 2024 | 206.99% |
| Sep 30, 2024 | -150.73% |
| Jun 30, 2024 | 241.78% |
| Mar 31, 2024 | -62.52% |
| Dec 31, 2023 | 1,079.89% |
| Sep 30, 2023 | -158.39% |
| Jun 30, 2023 | 548.12% |
| Mar 31, 2023 | -114.60% |
| Dec 31, 2022 | 142.27% |
| Sep 30, 2022 | -27.44% |
| Jun 30, 2022 | -170.13% |
| Mar 31, 2022 | -22.75% |
| Dec 31, 2021 | 43.89% |
| Sep 30, 2021 | -48.77% |
| Jun 30, 2021 | -180.61% |